MPAC Group PLC

MPAC Group PLC has a market capitalization of £7.67 billion and a price-to-book ratio of 101.84, indicating a significant premium to its book value. The company's liquidity position is assessed as medium, with a current ratio of 0.73 and negative net cash after subtracting total debt. Free cash flow is negative at £4.9 million, and operating cash flow is modest at £1.6 million. Profitability metrics are weak, with a return on equity of -12.62% and a return on assets of -4.29%. The company reported a net loss of £9.5 million and an operating loss of £5.2 million in the latest period. Gross profit of £63.2 million represents 36.3% of revenue, but this is insufficient to cover operating expenses. The company operates in three geographic regions: Americas, EMEA, and Asia Pacific. Revenue concentration data is not provided, but the company serves multiple sectors, including health and personal care/pharmaceuticals, food and beverage, consumer goods, and clean energy. MPAC Group PLC's revenue for the latest period was £174.1 million. Analysts have set a mean price target of £575.00, significantly higher than the current market price of £255.00. The company's outlook for the current fiscal year is not explicitly provided, but the negative operating and net income suggest a challenging near-term performance. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag. No significant dilution sources are identified in the latest filings, and the dilution potential is assessed as low. Recent events include the publication of the latest financial snapshot and analyst price targets. No specific recent filings or transcripts are provided in the input data. The company's capital expenditure of £4.7 million and free cash flow of -£4.9 million suggest ongoing investment in operations, but this is not yet generating positive cash returns.